Tomicid (Solution) Instructions for Use
Marketing Authorization Holder
Biomed named after I.I.Mechnikov, PJSC (Russia)
ATC Code
D06BX (Other chemotherapeutic preparations for topical use)
Dosage Forms
| Tomicid | Solution for topical and external use: 90 ml bottle | |
| Solution for topical and external use: 200 ml bottle |
Dosage Form, Packaging, and Composition
Solution for topical and external use light brown in color, transparent, with a sour taste.
| 1 bottle | |
| Tomicid (sterile metabolite product of non-pathogenic streptococcus Streptococcus sp. TOM-1606) | 90 ml |
90 ml – bottles (1) – cardboard packs.
Solution for topical and external use light brown in color, transparent, with a sour taste.
| 1 bottle | |
| Tomicid (sterile metabolite product of non-pathogenic streptococcus Streptococcus sp. TOM-1606) | 200 ml |
200 ml – bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Antibacterial drug
Pharmacotherapeutic Group
MIBP
Pharmacological Action
Tomicid has a bactericidal effect against gram-positive cocci.
Indications
- Varicose veins with and without ulcers;
- Tonsillitis;
- Pyoderma;
- Open wounds;
- Wound suppuration;
- Prevention of postoperative wound suppuration;
- Other local infections of the skin and subcutaneous tissue;
- Decubitus ulcer;
- Other ulcers of the lower limb.
The use of the drug is allowed for associations of gram-positive cocci with other pathogens.
ICD codes
| ICD-10 code | Indication |
| I83.2 | Varicose veins of lower extremities with ulcer and inflammation |
| J03 | Acute tonsillitis |
| L01 | Impetigo |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L03 | Cellulitis |
| L08.0 | Pyoderma |
| L30.3 | Infectious dermatitis (infectious eczema) |
| L73.2 | Hidradenitis suppurativa |
| L89 | Decubitus ulcer and pressure area |
| T14.1 | Open wound of unspecified body region |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| ICD-11 code | Indication |
| 1B70.1 | Streptococcal cellulitis of the skin |
| 1B70.2 | Staphylococcal cellulitis of the skin |
| 1B70.Z | Bacterial cellulitis or lymphangitis caused by unspecified bacterium |
| 1B72.0 | Bullous impetigo |
| 1B72.1 | Nonbullous impetigo |
| 1B72.Z | Impetigo, unspecified |
| 1B75.0 | Furuncle |
| 1B75.1 | Carbuncle |
| 1B75.2 | Furunculosis |
| 1B75.3 | Pyogenic skin abscess |
| BD74.Z | Chronic venous insufficiency of lower extremities, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| EA88.0Z | Infectious dermatitis, unspecified |
| EB21 | Pyoderma gangrenosum |
| ED92.0 | Hidradenitis suppurativa |
| EH90.Z | Pressure ulcer of unspecified degree |
| ND56.1 | Open wound of unspecified body region |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
The drug is used externally.
Treatment of tonsillitis
When treating tonsillitis, Tomicid is used as a gargle. A single dose of Tomicid for gargling is 10-15 ml. The drug is recommended to be used warmed (from 37 to 42°C (107.6°F))
Contact with the surface of the mucous membrane should be 3-5 minutes. The frequency of gargling is 5-6 times a day. The duration of use is until the symptoms of the disease disappear.
Treatment of pyoderma
Tomicid is used for various forms of pyoderma
- For superficial strepto-staphylodermia;
- For deep forms of pyoderma (furuncles, carbuncles, hidradenitis);
- For secondary forms of pyoderma complicating the course of various dermatoses (eczema, neurodermatitis);
- For trophic ulcers complicated by secondary purulent infection.
Treatment is carried out by applying a wet dressing soaked in Tomicid to the affected areas 2-3 times a day, until the symptoms of the disease disappear.
Treatment of purulent wounds
Before using Tomicid, it is recommended to completely remove the purulent-necrotic substrate from the wound. Then the wound cavity is loosely tamponaded with Tomicid. Dressings are performed once a day until bleeding, succulent granulations appear in the wound. Subsequent treatment is carried out with Tomicid in combination with oil (vaseline or castor) in equal ratios, until the wound is completely healed.
The amount of Tomicid used per dressing depends on the size and shape of the purulent cavity and averages 5-10 ml.
Tomicid can be used to wash closed purulent cavities (fistulous tracts, chronic osteomyelitis, etc.) located in connective and bone tissue.
Prevention of postoperative wound suppuration
To prevent postoperative wound suppuration, Tomicid should be used in the form of wet dressings applied to the wound surface immediately after surgery once a day for the first 3-5 days. After this period, if there are no signs of inflammation, the use of Tomicid should be discontinued.
Adverse Reactions
When applying Tomicid to the affected area of the skin, a brief burning sensation may occur.
Contraindications
There are no contraindications to the use of Tomicid.
Use in Pregnancy and Lactation
Pregnancy and the period of breastfeeding are also not contraindications for the use of Tomicid.
Special Precautions
The drug is not suitable for use
- If the expiration date has passed;
- With unclear labeling;
- If the integrity of the bottles is compromised;
- If it becomes cloudy (before use, the bottle with Tomicid must be shaken and the transparency of the liquid checked. The cloudy drug is not suitable for use).
Complaints about the quality of the drug during the shelf life should be sent to the Federal State Budgetary Institution “L.A. Tarasevich State Institute for Standardization and Control of Medical Biological Preparations” of the Ministry of Health and Social Development of Russia (41 Sivtsev Vrazhek Lane, Moscow, 119002) and to the manufacturer.
Drug Interactions
The use of Tomicid in combination with other drugs (antibiotics, sulfonamides) is allowed.
Storage Conditions
Store in a dry place protected from light at a temperature of 2 to 10°C (50°F). Keep out of reach of children.
Shelf Life
Shelf life – 2 years. Do not use after the expiration date.
Dispensing Status
Available without a prescription.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Kagocel pills 12mg, 30pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Noopept, pills 10mg, 50pcs
Picamilon pills 50mg, 60pcs
OKI, sachets 80mg 2g, 12pcs
Cortexin, 10mg, 5ml, 10pcs
Daivobet, ointment, 30g
Actovegin pills 200mg, 50pcs
Belosalic, lotion solution for external use spray 100ml
Ingavirin capsules 90mg, 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Nootropil pills 800mg, 30pcs 